COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1945: Articles 19441-19450  | Next

Intention of health care workers to accept COVID-19 vaccination and related factors: a systematic review and meta-analysis
Galanis, P. A., Vraka, I., Fragkou, D., Bilali, A., Kaitelidou, D.
10.1101/2020.12.08.20246041 — Posted: 2020-12-11
Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma
Mishra, N., Kumar, S., Singh, S., Bansal, T., Jain, N., Saluja, S., Palanichamy, J. K., Mir, R. A., Sinha, S., Luthra, K.
10.1101/2020.12.09.418806 — Posted: 2020-12-10
SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential
Vithani, N., Ward, M. D., Zimmerman, M. I., Novak, B., Borowsky, J. H., Singh, S., Bowman, G. R.
10.1101/2020.12.10.420109 — Posted: 2020-12-10
Coiled-coil heterodimers with increased stability for cellular regulation and sensing SARS-CoV-2 spike protein-mediated cell fusion
Plaper, T., Aupic, J., Dekleva, P., Lapenta, F., Mancek, M., Jerala, R., Bencina, M.
10.1101/2020.12.10.419440 — Posted: 2020-12-10
An interactive viral genome evolution network analysis system enabling rapid large-scale molecular tracing of SARS-CoV-2
Ling, Y., Cao, R., Qian, J., Li, J., Zhou, H., Yuan, L., Wang, Z., Zheng, G., Zhao, G., Li, Y., Wang, Z., Zhang, G.
10.1101/2020.12.09.417121 — Posted: 2020-12-10
Betulonic acid derivatives inhibiting coronavirus replication in cell culture via the nsp15 endoribonuclease
Krasniqi, B., Stevaert, A., Van Loy, B., Nguyen, T., Thomas, J., Vandeput, J., Jochmans, D., Thiel, V., Dijkman, R., Dehaen, W., Voet, A., Naesens, L.
10.1101/2020.12.10.418996 — Posted: 2020-12-10
Molnupiravir (EIDD-2801) inhibits SARS-CoV2 replication in Syrian hamsters model
Abdelnabi, R., Foo, C. S., Kaptein, S. J. F., Zhang, X., Langendries, L., Vangeel, L., Vergote, V., Heylen, E., Dallmeier, K., Chatterjee, A., De Jonghe, S., Weynand, B., Neyts, J.
10.1101/2020.12.10.419242 — Posted: 2020-12-10
A single dose, BCG-adjuvanted SARS-CoV-2 vaccine induces Th1-polarized immunity and high-titre neutralizing antibodies in mice
Counoupas, C., Stella, A., Bhattacharyya, N., Grey, A., Patel, K., Ferguson, A., Hutchings, O., Feng, C., Palendira, U., Steain, M., Aggarwal, A., Low, J., Mackay, J., Kelleher, A., Britton, W., Turville, S., Triccas, J. A.
10.1101/2020.12.10.419044 — Posted: 2020-12-10
SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray
Pyrc, K., Milewska, A., Duran, E. B., Botwina, P., Lopes, R., Arenas-Pinto, A., Badr, M., Mellor, R., Kalber, T., Fernandez-Reyes, D., Schatzlein, A. G., Uchegbu, I. F.
10.1101/2020.12.10.413609 — Posted: 2020-12-10
Social Media Insights Into US Mental Health Amid the COVID-19 Pandemic. A Longitudinal Twitter Analysis (JANUARY-APRIL 2020)
Valdez, D., ten Thij, M., Bathina, K. C., Rutter, L. A., Bollen, J.
10.1101/2020.12.01.20241943 — Posted: 2020-12-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).